Biogen Pharmachem Industries Ltd
₹0.00▲ +0.00 (+0.00%)
BIOGENPHARMACHEMLTD·NSE·Financial Services
Market Cap
28.40 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
0.81 - 0.26
₹0.00▲ +0.00 (+0.00%)
Market Cap28.40 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low0.81 - 0.26
Biogen Pharmachem Industries Ltd (BIOGENPHARMACHEMLTD): company summary
Biogen Pharmachem Industries Ltd (BIOGENPHARMACHEMLTD) is a micro-cap Financial Services company valued at ₹28 crore operating in Other Financial Services on the NSE and BSE.
Biogen Pharmachem Industries Ltd (BIOGENPHARMACHEMLTD) is a micro-cap Financial Services company valued at ₹28 crore operating in Other Financial Services on the NSE and BSE.
- Financial performance
- Profit grew 25.1% a year. Return on equity is 0.9%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.29 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.2/10
Weak
Fair Value
Sign in to see
ROE
0.90%
Weak
P/E
—
Debt / Equity
0.00
Low
Industry
Financial Services
Other Financial Services
Overall View
Mixed
Price performance
52W₹0.26
₹0.81
DocStoX take
Supported by growth (8.1) and valuation (7.5), but held back by quality (0.8). Growth looks strong at 8.1, but that is offset by quality at 0.8. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.2
/10
Weak
Quality
Weak
ROE 0.9%
Valuation
Cheap
P/B 0.3× vs 0.6× warranted by ROE
Growth
Strong
Revenue +9.9% 5Y CAGR
Risk
Elevated
D/E 0.00 (lender)
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹28 Cr
52W High / Low
₹1 / ₹0
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹0.00
Book Value
₹0.94
Key highlights
- Profit compounding 25% a year
- Loss-making in some of the last 5 years
- Quality is weak (0.8/10)
1 Positive3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Financial Services stocks · Other Financial Services
Explore Biogen Pharmachem Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Biogen Pharmachem Industries Ltd peers in Financial Services
Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.
HDFC Bank LimitedICICI Bank LimitedState Bank of IndiaBajaj Finance LimitedLife Insurance Corporation Of IndiaKotak Mahindra Bank LimitedAxis Bank LimitedBajaj Finserv LimitedShriram Finance LimitedSBI Life Insurance Company LimitedJio Financial Services LimitedICICI Prudential Asset Management Company Limited
Compare Biogen Pharmachem Industries Ltd with peers
Biogen Pharmachem Industries Ltd vs HDFC Bank LimitedBiogen Pharmachem Industries Ltd vs ICICI Bank LimitedBiogen Pharmachem Industries Ltd vs State Bank of IndiaBiogen Pharmachem Industries Ltd vs Bajaj Finance LimitedBiogen Pharmachem Industries Ltd vs Life Insurance Corporation Of IndiaBiogen Pharmachem Industries Ltd vs Kotak Mahindra Bank Limited
Related tools & concepts
Value Biogen Pharmachem Industries Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing